levodopa has been researched along with Nausea in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (64.29) | 18.7374 |
1990's | 5 (8.93) | 18.2507 |
2000's | 8 (14.29) | 29.6817 |
2010's | 5 (8.93) | 24.3611 |
2020's | 2 (3.57) | 2.80 |
Authors | Studies |
---|---|
Feldman, M; Margolesky, J; Marmol, S; Singer, C | 1 |
Do, JH; Pepe, D | 1 |
de Deus-Fonticoba, T; Santos-Garcia, D | 1 |
Gorska, KI; Haruki, H; Johnsson, K; Pedersen, MG; Pojer, F | 1 |
Ellmén, J; Kieburtz, K; Kuoppamäki, M; Vahteristo, M | 1 |
Cicero, CE; Contrafatto, D; Dibilio, V; Luca, A; Mostile, G; Nicoletti, A; Raciti, L; Sciacca, G; Vasta, R; Zappia, M | 1 |
Lees, A; Obeso, J; Olanow, CW | 1 |
Pagonabarraga, J; Rodríguez-Oroz, MC | 1 |
Hauser, RA; Hubble, JP; Truong, DD | 1 |
Hauser, RA | 1 |
Swope, DM | 1 |
Guarnieri, M; Hubble, J; Koller, W; Rabinowicz, AL; Silver, D | 1 |
Carlsson, M; Ganowiak, W; Granérus, AK; Lorefält, B; Pålhagen, S; Toss, G; Unosson, M | 1 |
Comella, CL; Janko, K; Morrissey, M | 1 |
Morris, JG | 4 |
Bouchard, S; Grimes, JD; King, DB; Kofman, OS; Molina-Negro, P; Wilson, AF | 1 |
Fischer, PA; Hubener, K; Schneider, E | 1 |
Agid, Y; Illas, A; Lhermitte, F; Quinn, N | 1 |
Ahlskog, JE; Dewey, RB; Maraganore, DM; Matsumoto, JY | 1 |
Gachoud, JP; Gasser, U; Ghika, J | 1 |
Kuritzky, A; Melamed, E; Merims, D; Ziv, I; Zoldan, J | 1 |
Marsden, CD; Parkes, JD; Tarsy, D | 2 |
Birket-Smith, E; Dupont, E; Hansen, E; Hyyppä, M; Marttila, R; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rinne, UK | 1 |
Gilland, O | 1 |
Durand, JP; Gautier, JC | 1 |
Diamond, SG; Markham, CH; Treciokas, LJ | 2 |
Lance, JW; Mackenzie, RA | 1 |
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM | 1 |
Bladin, PF; Donnan, GA; Vajda, FJ | 1 |
Gerlach, J | 1 |
Ward, HW | 1 |
Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
Girke, W; Xenakis, Ch | 1 |
Baker, AB; Lee, MC; Loewenson, RB; Martin, WE; Resch, JA; Tolosa, ES | 1 |
Constantinidis, J; Dick, P; Tissot, R; Yanniotis, G | 1 |
De la Vega, CE; Friesen, HG; Lal, S; Martin, JB | 1 |
Niinimäki, A | 1 |
Holmsen, R | 1 |
Kempi, V; von Scheele, C | 1 |
Marsden, CD; Quinn, NP; Steiger, MJ | 1 |
Fahn, S | 1 |
Baumann, G; Chin, L; Lieberman, A | 1 |
Critchley, P; Parkes, D | 1 |
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
Glasgow, GL; Henley, JW; Willoughby, EW | 1 |
Holmsen, R; Presthus, J | 1 |
Il'inskiĭ, IA; Safronov, VA; Vasin, NIa | 1 |
Dostál, T; Kabes, J; Taussigová, D; Vinar, O | 1 |
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA | 1 |
8 review(s) available for levodopa and Nausea
Article | Year |
---|---|
Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?
Topics: Amantadine; Animals; Antiparkinson Agents; Confusion; Delayed-Action Preparations; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parkinson Disease | 2021 |
Pooled analysis of phase III with entacapone in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Catechols; Clinical Trials, Phase III as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Nitriles; Parkinson Disease; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline | 2014 |
[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
Topics: Antiparkinson Agents; Attention; Clinical Trials as Topic; Cognition Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Fatigue; Headache; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Motor Activity; Multicenter Studies as Topic; Nausea; Neuroprotective Agents; Parkinson Disease; Severity of Illness Index | 2013 |
Rapid treatment of "wearing off" in Parkinson's disease.
Topics: Antiemetics; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parkinson Disease; Salvage Therapy; Time Factors | 2004 |
The management of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease | 1982 |
A review of some aspects of the pharmacology of levodopa.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Cardiovascular System; Chemical Phenomena; Chemistry; Corpus Striatum; Delayed-Action Preparations; Dopamine; Humans; Hypotension, Orthostatic; Intestinal Absorption; Levodopa; Nausea; Neural Pathways; Parkinson Disease; Receptors, Dopamine; Substantia Nigra; Tissue Distribution; Vomiting | 1978 |
[Side-effects of L-dopa therapy].
Topics: Arrhythmias, Cardiac; Basal Ganglia Diseases; Depression; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Sex Factors; Time Factors; Vomiting | 1975 |
Parkinson's disease and levodopa. A five-year follow-up and review.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Animals; Athetosis; Basal Ganglia; Chorea; Corpus Striatum; Dementia; Depression; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Sexual Behavior; Substantia Nigra; Vomiting | 1974 |
22 trial(s) available for levodopa and Nausea
Article | Year |
---|---|
Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Topics: Adenosine A2 Receptor Antagonists; Aged; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Chronic Disease; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Nausea; Parkinson Disease; Purines; Safety; Selegiline; Treatment Outcome | 2003 |
Levodopa/carbidopa/entacapone (Stalevo).
Topics: Aged; Antiparkinson Agents; Area Under Curve; Biological Availability; Carbidopa; Catechols; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Evaluation; Female; Headache; Humans; Levodopa; Male; Middle Aged; Nausea; Nitriles; Reference Values; Therapeutic Equivalency | 2004 |
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
Topics: Adult; Aged; Carbidopa; Catechols; Drug Combinations; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 2005 |
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome | 2005 |
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting | 1981 |
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
Topics: Administration, Intranasal; Antiemetics; Antiparkinson Agents; Apomorphine; Benzamides; Carbidopa; Dopamine Agonists; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1996 |
Clinical efficacy and tolerability of a new levodopa/benserazide dual-release formulation in parkinsonian patients. L-Dopa Dual-Release Study Group.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Patient Dropouts; Psychomotor Agitation | 1997 |
[Apomorphine for treatment of "off-periods" in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Domperidone; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1999 |
Letter: Metoclopramide in parkinsonism.
Topics: Clinical Trials as Topic; Humans; Levodopa; Metoclopramide; Nausea; Parkinson Disease; Promethazine; Vomiting | 1975 |
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Vomiting | 1975 |
[Levodopa and decarboxylase inhibitors in Parkinson's disease].
Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1977 |
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary | 1977 |
A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
Topics: Adult; Benserazide; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1978 |
An evaluation of bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 1978 |
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1976 |
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting | 1977 |
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Evaluation; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Piperazines; Pyrimidines; Tremor | 1975 |
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine | 1975 |
The effects of combining carbidopa with levodopa for Parkinson's disease.
Topics: Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease; Vomiting | 1975 |
Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men.
Topics: Adult; Apomorphine; Benztropine; Blood Glucose; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Nausea; Placebos; Radioimmunoassay | 1975 |
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting | 1974 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting | 1974 |
26 other study(ies) available for levodopa and Nausea
Article | Year |
---|---|
Analyzing Apomorphine-Mediated Effects in a Cell Model for Parkinson's Disease with Partial Least Squares Structure Equation Modeling.
Topics: Apomorphine; Dopamine Agonists; Female; Humans; Hypotension, Orthostatic; Least-Squares Analysis; Levodopa; Male; Microarray Analysis; Nausea; Parkinson Disease; Transcriptome | 2020 |
[Initiation of levodopa enteral infusion: is always the test with nasojejunal tube really necessary?]
Topics: Aged; Antiparkinson Agents; Female; Humans; Infusions, Parenteral; Intubation, Gastrointestinal; Jejunum; Levodopa; Middle Aged; Nasal Cavity; Nausea; Patient Acceptance of Health Care; Unnecessary Procedures; Vomiting | 2018 |
Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs.
Topics: 5-Hydroxytryptophan; Adult; Alcohol Oxidoreductases; Anti-Infective Agents; Biopterins; Cell Line; Central Nervous System; Crystallography, X-Ray; Fibroblasts; Humans; Levodopa; NADP; Nausea; Pneumonia, Pneumocystis; Protein Conformation; Structure-Activity Relationship; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2013 |
Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Retrospective Studies; Vomiting | 2017 |
Levodopa therapy for Parkinson's disease: challenges and future prospects.
Topics: Activities of Daily Living; Antiparkinson Agents; Humans; Hypotension; Levodopa; Nausea; Parkinson Disease; Quality of Life; Vomiting | 2008 |
Stalevo for Parkinson's disease.
Topics: Carbidopa; Catechols; Diarrhea; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Nausea; Nitriles; Parkinson Disease | 2004 |
Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Deglutition Disorders; Female; Follow-Up Studies; Humans; Levodopa; Male; Motor Activity; Movement Disorders; Nausea; Parkinson Disease; Smell; Weight Loss | 2005 |
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease | 1984 |
Bromocriptine in the management of end of dose deterioration in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease | 1984 |
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1983 |
Bromocriptine in parkinsonism. A long-term study.
Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System | 1978 |
Patterns of response to levodopa in Parkinson's disease.
Topics: Aged; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 1978 |
[Abnormal movements induced by L-dopa. New therapeutic possibilities].
Topics: Heartburn; Humans; Indenes; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Pyridines; Time Factors | 1975 |
Levodopa and psoriasis.
Topics: Adult; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Psoriasis | 1975 |
[L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].
Topics: Aged; Drug Combinations; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced; Vomiting | 1976 |
Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benserazide; Bromocriptine; Child; Dopamine Agents; Drug Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Nausea; Restless Legs Syndrome; Time Factors | 1990 |
Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1991 |
A therapeutic approach to tardive dyskinesia.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors | 1985 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Transdihydrolisuride in parkinsonism.
Topics: Aged; Blood Pressure; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1987 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
The treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1985 |
Editorial: Dopa decarboxylase inhibitors.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Drug Combinations; Humans; Levodopa; Nausea; Parkinson Disease; Vomiting | 1974 |
Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease; Prognosis; Psychological Tests; Time Factors | 1974 |
[L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
Topics: Cardiovascular Diseases; Dyspepsia; Fear; Hallucinations; Humans; Hyperkinesis; Levodopa; Mental Disorders; Nausea; Parkinson Disease; Postoperative Care; Preoperative Care; Vomiting | 1974 |
L-dopa and tricyclic antidepressants in affective disorders. A pilot study.
Topics: Adult; Amitriptyline; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nausea; Nortriptyline; Pilot Projects; Vomiting | 1974 |